Dr. Ashley Birkett is the Director of PATH’s Malaria Vaccine Initiative (MVI), which accelerates the development of malaria vaccines and catalyzes timely access in endemic countries. He has 20 years of vaccine development experience, with 12 years spent in the vaccine biotechnology industry, where he led the advancement of novel influenza and malaria vaccine candidates from research through first-in-human clinical studies, and the last eight years at PATH. In addition to his leadership role at MVI, he serves on PATH’s Leadership and Product Development Leadership Teams. Dr. Birkett earned a PhD in Biochemistry and Molecular Biophysics from Virginia Commonwealth University. He has a BSc (Honors) in Applied Biological Sciences from the University of the West of England in the United Kingdom.